Amy Sater to Antineoplastic Agents
This is a "connection" page, showing publications Amy Sater has written about Antineoplastic Agents.
Connection Strength
0.527
-
Targeting the p53-MDM2 pathway for neuroblastoma therapy: Rays of hope. Cancer Lett. 2021 01 01; 496:16-29.
Score: 0.321
-
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future. Pharmacol Rev. 2024 May 02; 76(3):414-453.
Score: 0.206